Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C

Slides:



Advertisements
Similar presentations
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Identification of a Novel TP53 Cancer Susceptibility.
Advertisements

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Figure 1. RT–PCR identification of an abnormal transcript of the PTPN6 gene in normal and leukemic bone marrow cells and cell line. (a) Diagrammatic representation.
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
MLANA/MART1 and SILV/PMEL17/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma  Jinyan Du, Arlo J. Miller, Hans R. Widlund, Martin.
Volume 7, Issue 5, Pages (November 2016)
Imprinting-Mutation Mechanisms in Prader-Willi Syndrome
KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma  Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.
Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia by Chun-Lin Chen, Qing Liu, Ching-Hon Pui,
Promoter Methylation and Differential Expression of π-Class Glutathione S-Transferase in Endometrial Carcinoma  Queeny K.Y. Chan, Ui-Soon Khoo, Kelvin.
Hypomethylation Status of CpG Sites at the Promoter Region and Overexpression of the Human MDR1 Gene in Acute Myeloid Leukemias by Masaharu Nakayama, Morimasa.
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Michael A. Pulsipher, Christina Peters, Ching-Hon Pui 
A Case of FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia with a Rare FIP1L1 Breakpoint  Frédéric Lambert, Pierre Heimann, Christian Herens, Alain.
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells  Youwen Yang, PhD, Hans Michael Haitchi, MD,
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density  Pang-Kuo Lo, Hanano Watanabe, Pi-Chun.
Volume 1, Issue 2, Pages (March 2002)
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
by Sanjai Sharma, and Alan Lichtenstein
Gene expression profiling of pediatric acute myelogenous leukemia
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis  Seungjae Lee, Sumit Borah, Armita.
Discordance between Genetic and Epigenetic Defects in Pseudohypoparathyroidism Type 1b Revealed by Inconsistent Loss of Maternal Imprinting at GNAS1 
Jeung-Yeal Ahn, Katie Seo, Olga Weinberg, Scott D. Boyd, Daniel A
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Volume 29, Issue 1, Pages (April 2014)
Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia by Floriana Manodoro, Jacek Marzec, Tracy.
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Volume 133, Issue 6, Pages (December 2007)
Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues 
Differential DNA Methylation as a Tool for Noninvasive Prenatal Diagnosis (NIPD) of X Chromosome Aneuploidies  Floriana Della Ragione, Paola Mastrovito,
Ying-Ying Yu, Ph. D. , Cui-Xiang Sun, Ph. D. , Yin-Kun Liu, Ph. D
Volume 42, Issue 4, Pages (April 2005)
Allele-Specific Methylome and Transcriptome Analysis Reveals Widespread Imprinting in the Human Placenta  Hirotaka Hamada, Hiroaki Okae, Hidehiro Toh,
Rare Missense and Synonymous Variants in UBE1 Are Associated with X-Linked Infantile Spinal Muscular Atrophy  Juliane Ramser, Mary Ellen Ahearn, Claus.
Volume 7, Issue 5, Pages (November 2016)
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Structure of the GM2A Gene: Identification of an Exon 2 Nonsense Mutation and a Naturally Occurring Transcript with an In-Frame Deletion of Exon 2  Biao.
KIT Is a Frequent Target for Epigenetic Silencing in Cutaneous Melanoma  Christina Dahl, Cecilie Abildgaard, Rikke Riber-Hansen, Torben Steiniche, Johanne.
Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage  R.F. Loeser, M.D., H.-J. Im, Ph.D., B. Richardson,
Volume 10, Issue 6, Pages (June 2018)
Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease  Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,
Molecular Monitoring of Chronic Myelogenous Leukemia
A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer  D.Gareth R. Evans, Elke.
Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion  Zhengrui Xi, Lorne Zinman, Danielle Moreno, Jennifer Schymick,
Jianbo Song, Danielle Mercer, Xiaofeng Hu, Henry Liu, Marilyn M. Li 
Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer  Yan Jia, Yunsheng Yang, Qimin Zhan, Malcolm.
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis  Jonathan Mill, Thomas Tang, Zachary Kaminsky, Tarang Khare, Simin.
Allelic Skewing of DNA Methylation Is Widespread across the Genome
Koji Suzuki, Tania Bustos, Richard A. Spritz 
A Mutation in the Variable Repeat Region of the Aggrecan Gene (AGC1) Causes a Form of Spondyloepiphyseal Dysplasia Associated with Severe, Premature.
Remco van Doorn, Willem H. Zoutman, Nelleke A. Gruis 
Increased DNA Methylation at the AXIN1 Gene in a Monozygotic Twin from a Pair Discordant for a Caudal Duplication Anomaly  N.A. Oates, J. van Vliet, D.L.
Epigenetic Control of the S100A6 (Calcyclin) Gene Expression
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
Wook Lew  Journal of Investigative Dermatology 
Mutations in CHEK2 Associated with Prostate Cancer Risk
Genetic and Epigenetic Regulation of Human lincRNA Gene Expression
Genomewide Association Analysis of Human Narcolepsy and a New Resistance Gene  Minae Kawashima, Gen Tamiya, Akira Oka, Hirohiko Hohjoh, Takeo Juji, Takashi.
Promoter hypermethylation of the AE2/SLC4A2 gene in PBC
Methylation status of IGFBPL1 in human breast cancer.
Epigenetic Allele Silencing Unveils Recessive RYR1 Mutations in Core Myopathies  Haiyan Zhou, Martin Brockington, Heinz Jungbluth, David Monk, Philip Stanier,
The ACIN1 Gene is Hypermethylated in Early Stage Lung Adenocarcinoma
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Identification of a New Splice Form of the EDA1 Gene Permits Detection of Nearly All X- Linked Hypohidrotic Ectodermal Dysplasia Mutations  Alex W. Monreal,
E. Ekelund, A. Sääf, M. Tengvall-Linder, E. Melen, J. Link, J
K. Miura, M. Obama, K. Yun, H. Masuzaki, Y. Ikeda, S. Yoshimura, T
Presentation transcript:

Epigenetic Regulation of Human γ-Glutamyl Hydrolase Activity in Acute Lymphoblastic Leukemia Cells  Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C. Ribeiro, Ching-Hon Pui, Mary V. Relling, William E. Evans  The American Journal of Human Genetics  Volume 79, Issue 2, Pages 264-274 (August 2006) DOI: 10.1086/505645 Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 1 Comparison of GGH activity in acute leukemia cells with different genetic and lineage subtypes. GGH activity was measured in leukemia cells isolated from diagnostic bone marrow aspirates from pediatric patients with ALL (n=93) or primary AML (n=6). Patients with ALL were grouped according to ALL lineage, DNA ploidy, number of chromosome 8, and whether the leukemia cells contain the E2A-PBX1 or TEL-AML1 gene fusion. Differences between pairs were assessed using the exact Wilcoxon-Mann-Whitney test. Boxes represent the 25%–75% quartiles, lines in the boxes represent the median level of GGH activity, whiskers represent the nonoutlier range, and circles represent the outliers. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 2 Relationship between GGH expression and GGH activity. GGH activity was measured in leukemia cells obtained at diagnosis from 34 children with BNHD-ALL. These patients had wild-type GGH and disomy of chromosome 8. A, GGH expression, as detected by Affymetrix gene expression array, was significantly correlated with GGH activity. Excluding the outlier indicated by the asterisk (*) (n=33), we obtained P<.0001 and R2=0.49; including the outlier (n=34), we obtained P=.0002 and R2=0.36. B, Verification of GGH expression by RT-PCR with primers that amplified the entire GGH coding region. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 3 CpG islands in the GGH promoter region. A, Two CpG islands in the GGH 5′ promoter region extend into intron 1. The CpG1 and CpG2 regions (shaded areas) are indicated relative to the A of the translation start codon, defined as nt +1. B, Sequence of the GGH promoter region (nt −905 to −118) of each allele in the Nalm6 cell line and primary leukemia cells from five cases of ALL, determined by bisulfite sequencing. GGH promoter methylation was confirmed by NMSP in all five cases (data not shown). Each box represents a CpG dinucleotide; methylated CpG sites are blackened; unmethylated CpG sites are unblackened. The polymorphisms at nt −649, −249, and −209 were used to define allelic methylation. C, Regulation of transcriptional activity of GGH promoter by selective in vitro methylation of CpG islands in the GGH promoter region. The left panel shows a schematic diagram of the individually methylated CpG islands within GGH promoter constructs linked to a luciferase reporter. Methylated CpG island fragments are blackened; unmethylated fragments are unblackened. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 4 GGH promoter methylation status in ALL cells. A, NMSP analysis of the GGH promoter in leukemia cells from 40 patients with BNHD-ALL. Two sets of primers were used to analyze the methylation status of GGH promoter CpG1 and CpG2. M = methylated PCR products; N = negative (unmethylated) control; P = positive (methylated) control; U = unmethylated PCR products. B, Hypermethylation of both CpG islands in the GGH promoter was associated with down-regulated GGH expression. GGH activity, RNA expression (Affymetrix array signal), and promoter methylation were measured in leukemia cells obtained at diagnosis from 40 children with BNHD-ALL. The germline genotype of GGH at nt 452 (C→T) was assessed by examining genomic DNA isolated from normal peripheral leukocytes from the same patients. Met = methylated; un-Met = unmethylated. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 5 GGH promoter methylation status in normal leukocytes and AML cells. A, NMSP analysis of the GGH promoter in normal peripheral leukocytes (white blood cells [WBC]) isolated from 22 children with ALL. M = methylated CpG island; U = unmethylated CpG island. B, NMSP analysis of the GGH promoter in leukemia cells isolated from six children with primary AML. C, Comparison of GGH expression in leukemia cells (ALL) and normal leukocytes (WBC) from patients with ALL (n=16). Group 1 includes patients whose leukemia cells contained methylated CpG1 and CpG2; group 2, patients whose leukemia cells contained methylated CpG1 but not methylated CpG2; and group 3, patients in whose leukemia cells CpG1 was not methylated. CpG1 was not methylated in the normal leukocytes (WBC) of all patients. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions

Figure 6 GGH phenotype, GGH genotype, and MTXPG accumulation. A, Genetic and epigenetic factors affecting GGH activity in leukemia cells from patients with ALL. Overall comparison was performed using the exact Kruskal-Wallis test (n=49; P<.0001). Pairwise comparison was performed using the exact Wilcoxon-Mann-Whitney test. WT = wild type. B, Comparison of GGH activity and MTXPG accumulation in BNHD-ALL cells without the E2A-PBX1 or TEL-AML1 gene fusion. Boxes represent the 25%–75% quartiles, lines in the boxes represent the median level, whiskers represent the nonoutlier range, and circles represent the outliers. The American Journal of Human Genetics 2006 79, 264-274DOI: (10.1086/505645) Copyright © 2006 The American Society of Human Genetics Terms and Conditions